GALENA BIOPHARMA-Wert mit Zukunft?
Entry into a Material Definitive Agreement, Results of Operations and Fina
https://biz.yahoo.com/e/160708/gale8-k.html
Galena Biopharma Announces Closing of Registered Direct Offering
http://www.nasdaq.com/press-release/...direct-offering-20160713-00950
News oder warum geht der Kurs hoch ?
Moderation
Zeitpunkt: 08.08.16 08:06
Aktion: Nutzer-Sperre für immer
Kommentar: Sonstiges
Zeitpunkt: 08.08.16 08:06
Aktion: Nutzer-Sperre für immer
Kommentar: Sonstiges
http://sleekmoney.com/...graded-at-zacks-investment-research/1361494/
Zitat:
Galena had cash and cash equivalents of approximately $19.6 million as of June 30, 2016, compared with $29.7 million as of December 31, 2015. The decrease of approximately $10.1 million in cash and cash equivalents from December 31, 2015 to June 30, 2016 was attributable primarily to $24.7 million used in operating activities, $1.1 million in selling expenses related to the sale of the Companys commercial products, and $4.8 million in payments on long-term debt. The decrease was partially offset by $20.2 million in net proceeds from issuance of common stock and warrants to purchase common stock in January 2016.
http://investors.galenabiopharma.com/investors/...Update/default.aspx
http://www.streetinsider.com/Analyst+Comments/...gation/11946041.html
Galena Biopharma to Present NeuVax (nelipepimut-S) Interim Safety Data at the European Society for Medical Oncology (ESMO) 2016 Congress
Date: Sunday, October 9, 2016
Time: 1:00 p.m. to 2:00 p.m. local time
Location: Hall E
http://investors.galenabiopharma.com//investors/...gress/default.aspx
ob ich meine momentane Depotleiche noch versilbern kann dieses Jahr ??
Galena Biopharma Presents GALE-301/GALE-302 Phase 1b Data at the American College of Surgeons Clinical Congress 2016
http://investors.galenabiopharma.com//investors/...-2016/default.aspx
http://biopharmcatalyst.com/news/2016/...-pdufa-date-set-for-april-29
Galena had cash and cash equivalents of approximately $24.5 million as of September 30, 2016, compared with $29.7 million as of December 31, 2015.
Cash per Share $0,225 ohne den Cashburn der letztn 2 Mon.
http://investors.galenabiopharma.com/investors/...Update/default.aspx
am Montag RS 1:20
http://investors.galenabiopharma.com/investors/...-Split/default.aspx
dazu ein neuer CFO
http://investors.galenabiopharma.com/investors/...fficer/default.aspx
Seite 22 steht was zum Thema Cashburn!
s2.q4cdn.com/425283004/files/doc_financials/quarterly/2016/Q3/Q3-2016-Earnings-Slides-9-Nov-16-Final.pdf
ab hier gehts weiter...
http://forum.finanzen.net/forum/...LE_nach_Split-t542897#pst_22185269
Und was ist mit positiven NEWS !? .... Fehlanzeige .... waren paar kleine und nette intraday-trade´s ... mehr nicht.... ansonsten FINGER WEG hier.... jedenfalls für mich..... ohne reale substanzielle Verbesserung ist die Aktie keinerlei Dollar wert zu investieren.
Viel Unterschied zu GBSN gibt es da nicht ;-)